View Grant Opportunity
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
National Institutes of Health
PAR-25-069
HHS-NIH11
General Information
$
Est. Program Funding:
Est. Program Funding:
January 7, 2027
Closing Date:
Closing Date:
Expected No. of Awards
$
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-25-069
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.
| Response Date | Jan 07, 2027 12:00:00 AM EST |
| Posting Date | Nov 18, 2024 12:00:00 AM EST |
| Archive Date | Feb 12, 2027 12:00:00 AM EST |
| Award Ceiling | |
| Award Floor | |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | Private institutions of higher education, Small businesses, Special district governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, State governments, County governments, Independent school districts, Native American tribal governments (Federally recognized), Others (see text field entitled "Additional Information on Eligibility" for clarification), Public and State controlled institutions of higher education, For profit organizations other than small businesses, Native American tribal organizations (other than Federally recognized tribal governments), Public housing authorities/Indian housing authorities, City or township governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-069.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.393: Cancer Cause and Prevention Research
- :